Author
Harvard UniversityORCID 0009-0009-1063-8829Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Shinkichi Takamori, Naoki Haratake, Atrayee Bhattacharya…·Donald W. Kufe
This study identifies M1C as a driver of sotorasib resistance in NSCLC KRAS G12C mutant tumors and shows that targeting M1C improves treatment outcomes.
Shinkichi Takamori, Naoki Haratake, Kentaro Nonaka…·Donald W. Kufe
This study shows M1C is necessary for daraxonrasib resistance in NSCLC KRAS(G12C) mutant cells and identifies M1C as a potential therapeutic target.
Kentaro Nonaka, Takeshi Wakasa, Hiroaki Ochiiwa…·Makoto Iimori
This study shows that shortening the G2 phase enhances cell death from DNA replication stress-inducing drugs, regardless of p53 status.
Takeshi Wakasa, Kentaro Nonaka, Akihito Harada…·Hiroyuki Kitao
This study shows that trifluridine induces aberrant mitosis and cytotoxicity in both p53-null and p53-GOF mutant cells, independent of p53 function.